股票關注板塊 Abbott Laboratories (ABt US)$雅培 (ABT.US)$ 日線圖表 -[看好 ↗ **]ABt US is currently holding above short term ascending trendline support. As long as price is holding above 117.30 support, a further push higher towards 1st resistance at 123.80 then next resistance at 131.20 is expected. Technical indicators are advocating for a bullish scenario as well. Altern...
施貴寶股票討論
Abbott Laboratories (ABt US) $雅培 (ABT.US)$
日線圖表 -[看好 ↗ **]ABt US is currently holding above short term ascending trendline support. As long as price is holding above 117.30 support, a further push higher towards 1st resistance at 123.80 then next resistance at 131.20 is expected. Technical indicators are advocating for a bullish scenario as well.
Altern...
📌 本週的PDUFA：
$ZLDPF： 🤔
‣ Dasiglucagon
‣ 先天性高胰島素血症
‣ PDUFA：10/08/24
📣 上週的PDUFA決定:
$Biofrontera (BFRI.US)$ : 已核准 ✅
⇨ Ameluz
‣ 日光性角化症
‣ PDUFA: 10/04/24 (sNDA)
$施貴寶 (BMY.US)$ : 已核准 ✅
⇨ 新輔助治療Opdivo (nivolumab) + 化療
‣ 非小細胞肺癌（围手术期治疗）
‣ PDUFA：10/08/24
跳空上漲
$施貴寶 (BMY.US)$ 股票上漲3.8%後，FDA批准Cobenfy作為成人精神分裂症的新治療，這標誌著數十年來對這種精神障礙的首個新型治療。
$永利度假村 (WYNN.US)$ 在摩根史坦利將該公司的強勢基本面與競爭對手相比進行超額評級後，股價上漲1.7%。
讓我們看看明天是否會受到喜愛，結束這一週
$Heron Therapeutics (HRTX.US)$ : 🤔
⇨ ZYNRELEF® 注射劑進入針
‣ 術後疼痛
‣ PDUFA：9/23/24（sNDA）
$施貴寶 (BMY.US)$ : 🤔
⇨ KarXt（xanomeline-trospium）
‣ 精神分裂症
‣ PDUFA: 9/26/24 (NDA)
$賽諾菲安萬特 (SNY.US)$ $再生元製藥公司 (REGN.US)$ : 🤔
⇨ Dupixent
‣ 慢性阻塞性肺病
‣ PDUFA: 9/27/24 (sBLA)
$百濟神州 (BGNE.US)$ $默沙東 (MRK.US)$ & $施貴寶 (BMY.US)$ : 🤔
⇨ 鐵司立單抗、基特路達、歐維克與耶爾...
暫無評論